Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)

CUSIP: 05337M104

Q3 2017 13F Holders as of 30 Sep 2017

Security type / class
Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
Total 13F shares
27,182,084
Total 13F value
$284,631,551
Holder snapshot 6 signals
Share change
-528,305
SEC-reported price per share
$10.50
Number of holders
79
Value change
-$5,504,957
Number of buys
35
Number of sells
27
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
98,762,388

Security key

05337M104

Report period

Q3 2017

Institutions

79

Top holders

10

AVDL full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2017 Previous quarter: Q2 2017 AVADEL PHARMACEUTICALS PLC SEC filings AVADEL PHARMACEUTICALS PLC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Broadfin Capital, LLC
Disclosed value leader
Broadfin Capital, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2017
13F Lead comparable stake: 4.2% Showing 1-6 of 15 holder rows.

Quick read

Broadfin Capital, LLC leads the comparable SEC ownership view at 4.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Broadfin Capital, LLC's linked filing trail.
Comparable ownership Top 5
Broadfin Capital, LLC 4.2%
DEERFIELD MANAGEMENT COMPANY, L.P. 3.7%
Janus Henderson Group Ltd. 2.2%
ACADIAN ASSET MANAGEMENT LLC 1.7%
MORGAN STANLEY 1.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Broadfin Capital, LLC
13F
Company
13F
4.2%
$45,592,000
4,133,464 shares
 — 30 Jun 2017
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
3.7%
$40,320,000
3,655,494 shares
 — 30 Jun 2017
Janus Henderson Group Ltd.
13F
Company
13F
2.2%
$24,100,000
2,184,911 shares
 — 30 Jun 2017
ACADIAN ASSET MANAGEMENT LLC
13F
Company
13F
1.7%
$18,444,000
1,672,207 shares
 — 30 Jun 2017
MORGAN STANLEY
13F
Company
13F
1.6%
$17,334,000
1,571,497 shares
 — 30 Jun 2017
DEUTSCHE BANK AG\
13F
Company
13F
1.6%
$16,991,000
1,540,546 shares
 — 30 Jun 2017
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
79
Shares
27,182,084
Rows available
79
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 holders
76
Q3 2017 holders
79
Holder diff
3
Investor Q2 2017 Shares Q3 2017 Shares Share Diff Share Chg % Q2 2017 value Q3 2017 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .